AUS
NZ
UK
CA
USA
IND
On July 23, 2026, QXO, Inc. announced the filing of a prospectus supplement to register the resale of convertible securities and common shares by designated stockholders. This filing stems from an Investment Agreement executed in January 2026 and includes about 41.4 million common shares issuable upon conversion of Series C Convertible Perpetual Preferred Stock, along with roughly 96,300 Preferred Stock shares held by named selling stockholders. This registration fulfills obligations under the strategic investment agreement and broadens the pool of publicly tradable securities linked to QXO's capitalization structure.
Key Points
- NYSE ticker: QXO-PB
- QXO, Inc. filed a prospectus supplement on July 23, 2026, registering resale rights for convertible preferred securities and underlying common shares pursuant to a January 5, 2026 Investment Agreement
- Registration covers 41,405,099 common shares convertible from Series C Convertible Perpetual Preferred Stock and 96,267 shares of Preferred Stock itself
- Prospectus supplement references QXO's existing Form S-3ASR registration statement filed July 29, 2024, and includes legal opinions from Paul, Weiss, Rifkind, Wharton & Garrison LLP
Foundation of Investment Agreement and Registration Compliance
QXO, Inc. entered into an Investment Agreement dated January 5, 2026, with multiple investors, creating registration obligations for specific securities. The company satisfied these requirements by filing a prospectus supplement on July 23, 2026. This supplement is filed under the umbrella of QXO's broader Form S-3ASR registration statement, initially submitted to the SEC on July 29, 2024. This linkage allows QXO to efficiently register secondary offerings by named selling stockholders without needing standalone registration statements.
Registration rights for convertible securities are common protective provisions in institutional investment deals. By filing the supplement, QXO establishes a legal framework enabling investors to liquidate or trade their holdings in the open market, subject to securities laws and resale conditions. The January 2026 investment involved both debt-like instruments—the Series C Convertible Perpetual Preferred Stock—and a significant number of underlying common shares obtainable upon conversion. The supplement formalizes the public resale availability of these securities by the named selling stockholders.
Scope of Convertible Securities and Preferred Stock Registered
The prospectus supplement registers a substantial volume of convertible securities: 41,405,099 common shares issuable upon conversion of Series C Convertible Perpetual Preferred Stock, plus 96,267 Preferred Stock shares registered for resale. Although the supplement does not disclose conversion ratios, dilution timing, or conversion triggers, these figures indicate a significant equity commitment from the January 2026 investment round. The common share equivalents represent a notable portion of potential future share count expansion upon conversion.
Registering both Preferred Stock shares and underlying common shares reflects the dual nature of convertible securities regulation. Preferred Stock holders may sell those shares directly or convert to common stock and sell publicly. By registering both, QXO provides multiple liquidity options. The filing does not disclose purchase price per preferred share, conversion price, dividend rates, or mandatory conversion conditions; interested parties should consult the full Investment Agreement or prospectus supplement via the SEC EDGAR database.
Registration Statement Framework and Legal Support
QXO utilizes its existing Form S-3ASR shelf registration statement—filed July 29, 2024, under File No. 333-281084—to register these securities. Shelf registrations enable issuers to pre-register securities for multiple future offerings, facilitating resale without new filings each time, provided sales occur within the shelf period. Incorporating the prospectus supplement into this framework streamlines administration and ensures compliance with Investment Agreement resale rights.
Using a prospectus supplement rather than a standalone prospectus enhances disclosure efficiency by updating the base prospectus without replacement, reducing redundancy. QXO engaged Paul, Weiss, Rifkind, Wharton & Garrison LLP to provide a legal opinion on the validity and proper registration of the shares. This opinion, filed as Exhibit 5.1, is incorporated into the S-3ASR registration statement, offering legal assurance to potential purchasers and resellers.
Characteristics of Series C Convertible Perpetual Preferred Stock
The Series C Convertible Perpetual Preferred Stock is a hybrid financing instrument combining features of debt and equity. "Perpetual" indicates no maturity date, unlike bonds. "Convertible" allows holders to exchange preferred shares for common stock under predetermined terms. The filing does not specify if mandatory conversion provisions apply. Such securities are common in growth-stage investments, offering downside protection via preferred rights or dividends while enabling upside through conversion.
Issuance of Series C Preferred Stock—following earlier series—suggests QXO employs a tiered capital structure catering to diverse investor risk profiles. The supplement does not disclose dividend rates, liquidation preferences, voting rights, or conversion mechanics; these details are likely in the supplement or Investment Agreement.
Regulatory Context for Resale Registration
Registration under Rule 415 of the Securities Act of 1933 fulfills contractual commitments allowing institutional investors to liquidate holdings. By filing the prospectus supplement, QXO complies with its obligations, providing SEC-approved documentation for public or broker-assisted resale by named stockholders. The filing timing—nearly six months post-Investment Agreement—is typical, reflecting preparation after investment close and capitalization.
The supplement's language confirms it satisfies registration duties under the January 2026 agreement. QXO also confirms it is not an emerging growth company, thus subject to full disclosure and auditing standards.
Legal Opinions and Documentation
Paul, Weiss, Rifkind, Wharton & Garrison LLP issued a legal opinion affirming the registered shares are validly issued, fully paid, and nonassessable, and that the registration statement properly covers the securities for resale. Filed as Exhibit 5.1, this opinion is crucial for underwriters, investors, and trading partners to confirm legal authorization and registration integrity. The firm's consent to use its opinion, filed as Exhibit 23.1, complies with regulatory requirements and underscores due diligence in the public filing process.
Impact on Capital Structure and Share Count
Registering 41.4 million common shares convertible from Series C Preferred Stock may affect QXO's future share count and dilute existing shareholders if conversion occurs. However, this filing does not trigger conversion events; it solely registers resale rights. Investors should monitor conversion terms and conditions disclosed elsewhere.
The company did not disclose current outstanding shares, fully diluted counts, or pro-forma ownership percentages, which are typically found in recent SEC filings such as 10-Q or 10-K reports. This supplement focuses narrowly on resale registration and does not provide a comprehensive capital structure overview.
Investor Liquidity and Market Implications
By registering these securities, QXO enables liquidity options for named selling stockholders from the January 2026 investment. These investors may sell common or Preferred Stock shares publicly, subject to trading restrictions like Rule 144 holding periods and volume limits. The supplement does not specify resale timing or volume; such decisions rest with investors and market conditions. Increased share float from resales could influence trading volumes and liquidity over time.
The supplement does not estimate resale quantities or timelines. Institutional holders often retain convertible or preferred securities long-term, selling based on liquidity needs or market conditions. Registration removes legal barriers but does not guarantee sales pace. Market participants and shareholders should consider potential impacts of large resales and conversion possibilities on share price and valuations.
Corporate Governance and Filing Transparency
The prospectus supplement was signed by Christopher Signorello, QXO's Chief Legal Officer, on July 23, 2026, indicating coordinated legal and compliance efforts with SEC electronic filing processes. The signature underscores responsibility for disclosure accuracy. The 8-K filing format is appropriate for material events like significant securities registration, complying with SEC regulations.
QXO's headquarters are in Greenwich, Connecticut. The company trades on the NYSE under ticker QXO for common stock. Its IRS Employer Identification Number is 16-1633636, and SEC file number is 001-38063, enabling investors to access related filings via public databases. The company is a Delaware corporation, standard for public entities, with established administrative systems for securities management.
